Louise Rodino-Klapac – Biography
Last update: February 27, 2026Executive profile
Louise was Principal Investigator at Nationwide Children's Hospital, and Chief Scientific Officer at Myonexus Therapeutics. Louise served as Senior Vice President, Gene Therapy at Sarepta Therapeutics.
Louise Rodino-Klapac is currentlyPresident, Research and Development and Technical Operations at Sarepta Therapeutics - View - Sarepta Therapeutics org chart
Create your alert
to follow the career of Louise Rodino-Klapac.
Education
Louise Rodino-Klapac has a Bachelor of Science in Biology, Chemistry & Molecular BiologyGradeSumma Cum Laude from King's College London in 2000 and a Doctor of Philosophy in Molecular Genetics from Ohio State University in 2005.
They have also studied at King's College London :
Find more alumni from King's College London
They have also studied at Ohio State University :
Find more alumni from Ohio State University
More about Louise Rodino-Klapac
Do you need to know more about Louise Rodino-Klapac? More results.
Participate
Social media
- Louise Rodino-Klapac on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Louise Rodino-Klapac
The colleagues of Louise Rodino-Klapac
Company Colleagues
- At Sarepta Therapeutics, Louise Rodino-Klapac has 37 colleagues including Douglas Ingram (CEO & Director (leaving)), Claude Nicaise (Director)…
Industry Colleagues
- In the Biotechnology industry, Louise Rodino-Klapac has 35,765 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Louise Rodino-Klapac.
Get in Touch
Here are a few tips for establishing great contacts.
